SCHEMBL6410343

SCHEMBL6410343

CN(CCOCCOCCOC(=O)c1ccccc1O)C(=N)N

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.52
▸ TSHR P16473 4/20 0.43
▸ LMNA P02545 2/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ SCN1A P35498 2/20 0.40
▸ SCN2A Q99250 2/20 0.40
▸ SCN3A Q9NY46 2/20 0.40
▸ SERPINE1 P05121 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ TP53 P04637 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ADRB2 P07550 1/20 0.38
▸ ADRB1 P08588 1/20 0.38
▸ ADRB3 P13945 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6407785 1.00 TDP1 (0.52) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6410563 0.93 TDP1 (0.56) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6414201 0.88 TDP1 (0.61) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6414108 0.87 TDP1 (0.60) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6415812 0.86 TDP1 (0.58) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6933315 0.86 TDP1 (0.58) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6409431 0.83 LMNA (0.50) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6409481 0.83 LMNA (0.50) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6061655 0.82 TDP1 (0.76) TDP1TSHRLMNAL3MBTL1ALDH1A1
SCHEMBL6063097 0.82 TDP1 (0.76) TDP1TSHRLMNAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050249692-A1 Polymer, cosmetic composition comprising same and method of preparing same MITSUBISHI CHEMICAL CORPORATION 2005-11-10 — — US disclosed
EP-1462463-A1 Guanidin-group containing polymer, cosmetic employing same and method of preparing same Mitsubishi Chemical Corporation (JP) 2004-09-29 — — EP disclosed
EP-0805674-B1 SKIN AND HAIR COSMETIC COMPOSITIONS KAO CORP (JP) 2003-03-12 — — EP disclosed
US-20020172655-A1 Cosmetic-use polymer, cosmetic employing same, and method of preparing same MITSUBISHI CHEMICAL CORPORATION 2002-11-21 — — US disclosed
EP-1236744-A2 Guanidin-group containing polymer, cosmetic employing same and method of preparing same MITSUBISHI CHEMICAL CORPORATION (JP) 2002-09-04 — — EP disclosed
US-6348200-B1 OXYALKYLAMIDE OR AMINE DERIVATIVES;AT LEAST ONE OF POLYHYDRIC ALCOHOLS, OR VEGETABLE EXTRACTS, OR ORGANIC ACIDS; IMPROVES WATER-RETAINING ABILITY OF HORNY LAYER, CURES ROUGHNESS AND PREVENTS WRINKLES KAO CORPORATION (JP) 2002-02-19 — — US disclosed
US-6187955-B1 A MOISTURIZER FOR SOFTENING SKINS; USEFUL AS COMPONENTS OF COSMETIC FORMULATIONS KAO CORPORATION (JP) 2001-02-13 — — US disclosed
US-5723133-A GUANIDINE WITH ORGANIC ACID FOR SKIN SOFTENING KAO CORPORATION (JP) 1998-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020172655-A1 Cosmetic-use polymer, cosmetic employing same, and method of preparing same DNMT1, PRMT1, JMJD6 TDP1 369/4885TSHR 3024/4885LMNA 1665/4885
US-20050249692-A1 Polymer, cosmetic composition comprising same and method of preparing same DNMT1, TET2, H1-0 TDP1 669/4885TSHR 2711/4885LMNA 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback